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(9.6 ± 1.2 to 7.6 ± 0.7 cm, p < 0.05) and in CI (676 ± 79 to 536 ± 65 cm/min,
p < 0.05). SO and Cl were unchanged after captopril in normals (SO, 7.7 ±
1.3 to 7.4 ± 0.6 cm; CI. 579 ± 117 to 571 ± 69 cm/min, both ns). There was
no reduction in forearm or digital skin vascular resistance after captopril in
either group. Basal PRA in AF was similar to normals, but did not rise after
captopril (691 ± 217 to 681 ± 221 pg/mllhr, ns), unlike normals (813 ± 103
to 1360 ± 290 pg/mllhr, p < 0.05). NORAO was unchanged after captopril in
both groups.
We conclude that. captopril lowers blood pressure in AF. unlike normals.
The depressor response in AF occurs independently of plasma renin levels
and sympathetic nervous activity, suggesting that alternative mechanisms,
including accumulation of bradykinin and prostaglandins, may be responsi-
ble.
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Conclusion: In severe CH F Six minute walk test is related to symptoms
and perceived exertion. The test also gives prognostic information and it is
related to functional classification.
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1788-31 Effect of Body Composition on Exercise Performance
in Patients with Heart Failure
John R. Wilson, Glenn Rayos, Jane Smith, Patricia Gothard, lK. Yeoh. VanderbJit
University; Nashville, TN
Changes in fat and skeletal muscle VOlume may contribute to the exercise in-
tolerance reported by patients with heart failure. To test this hypothesis, we
measured hemodynamic and ventilatory responses to exercise in 65 patients
with chronic heart failure. Body composition was determined by dual-energy
x-ray absorptiometry. Peak exercise V02 averaged 13.2 ± 2.9 ml/min/kg,
peak exercise cardiac index 4.5 ± 1.1 lImin/m2, lean body weight 55 ± 12 kg,
lean leg weight 17.2 ± 3.8 kg and total fat 27 ± 11 kg. Thirty-eight (58%) of
the patients were obese, as defined by a percentage fat >30%. Twenty-four
patients (37%) exhibited lean body wt/height <300 gm/cm, consistent with
muscle atrophy. Peak exercise V02 correlated closely with total leg muscle:
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1788-1 I The 6-Minute Walk Test Predicts Maximal Oxygen
Consumption and Survival in Advanced Heart Failure
Lawrence P. Cahalin, Thomas G. Di Salvo, Michael M. Mathier, Dennis
M. McNamara, Marc J. Semigran, G. William Dec Massachusetts General Hospital,
Harvard Medical School, Boston, MA
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Although maximal oxygen consumption (MV02) is useful in predicting prog-
nosis and need for cardiac transplantation (TX) in patients with advanced
heart failure (HF), its determination requires sophisticated equipment. The
six-minute walk test (6-MW) is a simple indirect measure of functional capac-
ity, and predicts survival in moderate HE To assess the predictive value of the
6-MW, MV02, and percent predicted age-sex adjusted MV02 (%MV02) in
advanced HF, 45 pts (age 49 ± 8 yrs mean ± SO, LVEF 0.20 ± 0.06, RVEF 0.31
± 0.11) underwent cardiopulmonary exercise testing (cycle ergometry) and
the 6-MW during TX evaluation. Mean 6-MW distance ambulated was 310
± 100 meters, MV02 12.2 ± 4.5 ml/kg/min, and %MV02 38 ± 11 %. Multi-
variate analysis of patient characteristics, resting hemodynamics and 6-MW
(age, sex, weight, peak HR and BP during the 6-MW, right and left ventric-
ular ejection fraction, right atrial pressure, mean pulmonary artery pressure,
and cardiac index) identified distance ambulated during the 6-MW as the
strongest predictor of MV02 (p < 0.000) and %MV02 (p < 0.0001. In univari-
ate survival analysis, 6-MW > 300 meters predicted survival to the combined
end-point death or hospital admission for inotropic/mechanical support (IN)
as a bridge to TX (p < 0.05). but not overall survival (p = 0.075). In multivariate
proportional hazards survival analysis designed to compare %MV02, MV02,
and 6-MW, MV02 was selected as the best predictor of overall survival, and
%MV02 as the best predictor of IN-free survival. 6-MW was not selected in
any multivariate analysis. Conclusions: In pts with advanced HF evaluated
for TX, distance ambulated during the 6-MW predicts 1) MV02 and %MV02
and 2) IN-free survival but not overall survival. MV02 and %MV02 may be
superior to the 6-MW as predictors of survival in these pts: however, further
studies to es1ablish the prognostic utility of the 6-MW in pts with advanced
HF are warranted.
10:45
Six Minute Walk Test Gives Prognostic Information in
Severe Hear Failure
Karl Swedberg, Robert M. Califf, Kirkwood Adams, Mlhai Gheorghiade, Frank
B. Harrel, William McKenna, Kenneth Schulman, Jorge Soler-Soler, Barry Uretsky,
F. Zannad, FIRST investigators. astra Hospital, G6teborg University; G6teborg,
Sweden
Distance walked in Six minute walk test (SMWTI has been shown to give
prognostic information in moderate heart failure. We studied the value of
SMWT in 359 patients with severe CHF (NYHA III-IV) in a multicenter trial of
continuous epoprostenol infusions. SMWT was performed in a 30 m long
corridor. Perceived symptoms were evaluated by the Borg scale. Follow up
was performed at 2 weeks, 1, 3, 6 and 9 months.
Results: SMWT at baseline was significantly related to survival (p =
0.0001). When SMWT distance was below median, 210 m, 6 month mor-
tality was 50% vs 20% above median (p < 0.001). Median Borg scale at end
of exercise was 3.2. A test with a Borg scale above median value was 174
m vs 230 m below median (p < 0.001). When all tests performed at baseline
and during follow up were included (n = 1291) and related to changes in
NYHA class, there was a significant relationship to NYHA class (p = 0.0001).
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There was no relationship between V02/9m leg muscle and the lean body
wt/height index. suggesting that muscle atrophy does not affect muscle per-
formance/unit of muscle. V02/kg muscle was higher in obese vs non-obese
patients (72 + 14 vs 59 + 13 mllmin/kg (p < 0.01) whereas peak V02/kg body
weight was similar (13.0 + 3.3 vs 13.2 + 2.6 mllmin/kg). since body weight
inCludes fat. These findings suggest that skeletal muscle volume influences
exercise capacity in patients with heart failure. Exercise capacity in obese
patients is underestimated by normalizing for body weight.
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1788-41 Does Low Level Training Increase Peak Aerobic
Capacity in Patients with Congestive Heart Failure?
Laura Demopoulos, Rachel Bijou. Icilma Fergus, Marco Gentilucci,
Leslie Panzarino, Margaret Jones, Marie Galvao, Edmund H. Sonnenblick, Thierry
H. LeJemtel. Albert Einstein College ofMedicine, Bronx, New York
Conventional high level exercise training at a workload consistent with 75%
of peak oxygen consumption (pV02, ml/min/kg) in patients with congestive
heart failure (CHF) improves peak aerobic capacity and limb vasodilatory ca-
pacity. However, training at this workload may promote left ventricular dilata-
tion in patients with CHF by prolonged exposure to substantially elevated
filling pressure (PCWP). Whether training at low level, I.e.. at a workload con-
sistent with <50% pV02, would result in limited increases in PCWP while
still improving peak aerobic capacity and peripheral vasodilatory function is
unknown. Accordingly, 15 patients with stable advanced CH F underwent
measurement of 1) the PCWP response to low vs high level exercise, and
2) the change in peak aerobic capacity and limb vasodilatory capacity re-
SUlting from participation in a low level training program. PCWP was mea-
sured by right heart catheterization at rest, and during low and high level
exercise. Patients then performed 12 weeks of low level training, utilizing a
semi-recumbent bicycle. Pre- and post-training evaluations included pV02,
calf and forearm peak hyperemic blood flow (PHBF, ml/min/1 00 mil. and rest-
ing heart rate (HR, bIminI.
Results: 1)PCWP rose to 20 mmHg during low level exercise (t..54% vs
rest), and 34 mmHg during high level exercise (t..162% vs rest). 2)Pre- and
post-training data are as follows:
pV02 calf PHBF forearm PHBF HR
pre~train 99 1B 23 99
post~train 14.1 36 20 BO
p value 0.02 <0.01 NS 002
Conclusions: 1) The rise in PCWP is significantly less during low level exer-
cise than during high level exercise. 2) Training at a workload consistent with
550% of pV02 significantly improves peak aerobic capacity. 3) PHBF in the
trained calf increases 100% from baseline, while it does not change in the
untrained forearm. Enhanced vasodilatory responses in exercising muscle
